The co-treatment group (TSN 0.5 mg/kg plus CPT 2mg/kg) exhibited the highest tumor growth inhibition effect, followed by TSN (1 mg/kg), CPT (2 mg/kg) and TSN (0.5 mg/kg) (Figure 8A, C, D). This evidence concerns the gene TSN and neoplasm.